カテゴリー： QYResearch, 世界, 医療/バイオ

世界のペット用寄生虫予防＆制御薬市場インサイト及び予測（局所薬、注射薬、経口薬）

◆英語タイトル：Global Pet Parasite Prevention and Control Drugs Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX10463）◆商品コード：QY22JLX10463
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：92
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、ペット用寄生虫予防＆制御薬のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にペット用寄生虫予防＆制御薬の世界市場のxxx％を占める「局所薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「犬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ペット用寄生虫予防＆制御薬の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのペット用寄生虫予防＆制御薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ペット用寄生虫予防＆制御薬のグローバル主要企業には、Boehringer Ingelheim、Bayer、Zoetis、Dechra Pharmaceuticals、Chanelle Pharma、Merck Animal Health、Elanco、Virbac、Vetoquinolなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ペット用寄生虫予防＆制御薬市場は、種類と用途によって区分されます。世界のペット用寄生虫予防＆制御薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
局所薬、注射薬、経口薬

【用途別セグメント】
犬、猫、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ペット用寄生虫予防＆制御薬製品概要
- 種類別市場（局所薬、注射薬、経口薬）
- 用途別市場（犬、猫、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のペット用寄生虫予防＆制御薬販売量予測2017-2028
- 世界のペット用寄生虫予防＆制御薬売上予測2017-2028
- ペット用寄生虫予防＆制御薬の地域別販売量
- ペット用寄生虫予防＆制御薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ペット用寄生虫予防＆制御薬販売量
- 主要メーカー別ペット用寄生虫予防＆制御薬売上
- 主要メーカー別ペット用寄生虫予防＆制御薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（局所薬、注射薬、経口薬）
- ペット用寄生虫予防＆制御薬の種類別販売量
- ペット用寄生虫予防＆制御薬の種類別売上
- ペット用寄生虫予防＆制御薬の種類別価格
・用途別市場規模（犬、猫、その他）
- ペット用寄生虫予防＆制御薬の用途別販売量
- ペット用寄生虫予防＆制御薬の用途別売上
- ペット用寄生虫予防＆制御薬の用途別価格
・北米市場
- 北米のペット用寄生虫予防＆制御薬市場規模（種類別、用途別）
- 主要国別のペット用寄生虫予防＆制御薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのペット用寄生虫予防＆制御薬市場規模（種類別、用途別）
- 主要国別のペット用寄生虫予防＆制御薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のペット用寄生虫予防＆制御薬市場規模（種類別、用途別）
- 主要国別のペット用寄生虫予防＆制御薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のペット用寄生虫予防＆制御薬市場規模（種類別、用途別）
- 主要国別のペット用寄生虫予防＆制御薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのペット用寄生虫予防＆制御薬市場規模（種類別、用途別）
- 主要国別のペット用寄生虫予防＆制御薬市場規模（トルコ、サウジアラビア）
・企業情報
Boehringer Ingelheim、Bayer、Zoetis、Dechra Pharmaceuticals、Chanelle Pharma、Merck Animal Health、Elanco、Virbac、Vetoquinol
・産業チェーン及び販売チャネル分析
- ペット用寄生虫予防＆制御薬の産業チェーン分析
- ペット用寄生虫予防＆制御薬の原材料
- ペット用寄生虫予防＆制御薬の生産プロセス
- ペット用寄生虫予防＆制御薬の販売及びマーケティング
- ペット用寄生虫予防＆制御薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ペット用寄生虫予防＆制御薬の産業動向
- ペット用寄生虫予防＆制御薬のマーケットドライバー
- ペット用寄生虫予防＆制御薬の課題
- ペット用寄生虫予防＆制御薬の阻害要因
・主な調査結果

Market Analysis and Insights: Global Pet Parasite Prevention and Control Drugs Market
Due to the COVID-19 pandemic, the global Pet Parasite Prevention and Control Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Topical Medication accounting for % of the Pet Parasite Prevention and Control Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Dog segment is altered to an % CAGR throughout this forecast period.
China Pet Parasite Prevention and Control Drugs market size is valued at US$ million in 2021, while the US and Europe Pet Parasite Prevention and Control Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pet Parasite Prevention and Control Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Pet Parasite Prevention and Control Drugs include Boehringer Ingelheim, Bayer, Zoetis, Dechra Pharmaceuticals, Chanelle Pharma, Merck Animal Health, Elanco, Virbac and Vetoquinol. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Pet Parasite Prevention and Control Drugs Scope and Segment
Pet Parasite Prevention and Control Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pet Parasite Prevention and Control Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Topical Medication
Injection Medication
Oral Medication
Segment by Application
Dog
Cat
Others
By Company
Boehringer Ingelheim
Bayer
Zoetis
Dechra Pharmaceuticals
Chanelle Pharma
Merck Animal Health
Elanco
Virbac
Vetoquinol
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Pet Parasite Prevention and Control Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Topical Medication
1.2.3 Injection Medication
1.2.4 Oral Medication
1.3 Market by Application
1.3.1 Global Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pet Parasite Prevention and Control Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Pet Parasite Prevention and Control Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Pet Parasite Prevention and Control Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pet Parasite Prevention and Control Drugs Sales by Region
2.4.1 Global Pet Parasite Prevention and Control Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Pet Parasite Prevention and Control Drugs by Region (2023-2028)
2.5 Global Pet Parasite Prevention and Control Drugs Revenue by Region
2.5.1 Global Pet Parasite Prevention and Control Drugs Revenue by Region (2017-2022)
2.5.2 Global Pet Parasite Prevention and Control Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pet Parasite Prevention and Control Drugs Sales by Manufacturers
3.1.1 Global Top Pet Parasite Prevention and Control Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Pet Parasite Prevention and Control Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pet Parasite Prevention and Control Drugs in 2021
3.2 Global Pet Parasite Prevention and Control Drugs Revenue by Manufacturers
3.2.1 Global Pet Parasite Prevention and Control Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pet Parasite Prevention and Control Drugs Revenue in 2021
3.3 Global Pet Parasite Prevention and Control Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pet Parasite Prevention and Control Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pet Parasite Prevention and Control Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pet Parasite Prevention and Control Drugs Sales by Type
4.1.1 Global Pet Parasite Prevention and Control Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Pet Parasite Prevention and Control Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Pet Parasite Prevention and Control Drugs Sales Market Share by Type (2017-2028)
4.2 Global Pet Parasite Prevention and Control Drugs Revenue by Type
4.2.1 Global Pet Parasite Prevention and Control Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Pet Parasite Prevention and Control Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Pet Parasite Prevention and Control Drugs Price by Type
4.3.1 Global Pet Parasite Prevention and Control Drugs Price by Type (2017-2022)
4.3.2 Global Pet Parasite Prevention and Control Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pet Parasite Prevention and Control Drugs Sales by Application
5.1.1 Global Pet Parasite Prevention and Control Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Pet Parasite Prevention and Control Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Pet Parasite Prevention and Control Drugs Sales Market Share by Application (2017-2028)
5.2 Global Pet Parasite Prevention and Control Drugs Revenue by Application
5.2.1 Global Pet Parasite Prevention and Control Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Pet Parasite Prevention and Control Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Pet Parasite Prevention and Control Drugs Price by Application
5.3.1 Global Pet Parasite Prevention and Control Drugs Price by Application (2017-2022)
5.3.2 Global Pet Parasite Prevention and Control Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pet Parasite Prevention and Control Drugs Market Size by Type
6.1.1 North America Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
6.1.2 North America Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2028)
6.2 North America Pet Parasite Prevention and Control Drugs Market Size by Application
6.2.1 North America Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
6.2.2 North America Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2028)
6.3 North America Pet Parasite Prevention and Control Drugs Market Size by Country
6.3.1 North America Pet Parasite Prevention and Control Drugs Sales by Country (2017-2028)
6.3.2 North America Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Pet Parasite Prevention and Control Drugs Market Size by Type
7.1.1 Europe Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
7.1.2 Europe Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2028)
7.2 Europe Pet Parasite Prevention and Control Drugs Market Size by Application
7.2.1 Europe Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
7.2.2 Europe Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2028)
7.3 Europe Pet Parasite Prevention and Control Drugs Market Size by Country
7.3.1 Europe Pet Parasite Prevention and Control Drugs Sales by Country (2017-2028)
7.3.2 Europe Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pet Parasite Prevention and Control Drugs Market Size by Type
8.1.1 Asia Pacific Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Pet Parasite Prevention and Control Drugs Market Size by Application
8.2.1 Asia Pacific Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Pet Parasite Prevention and Control Drugs Market Size by Region
8.3.1 Asia Pacific Pet Parasite Prevention and Control Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Pet Parasite Prevention and Control Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pet Parasite Prevention and Control Drugs Market Size by Type
9.1.1 Latin America Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
9.1.2 Latin America Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2028)
9.2 Latin America Pet Parasite Prevention and Control Drugs Market Size by Application
9.2.1 Latin America Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
9.2.2 Latin America Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2028)
9.3 Latin America Pet Parasite Prevention and Control Drugs Market Size by Country
9.3.1 Latin America Pet Parasite Prevention and Control Drugs Sales by Country (2017-2028)
9.3.2 Latin America Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pet Parasite Prevention and Control Drugs Market Size by Type
10.1.1 Middle East and Africa Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Pet Parasite Prevention and Control Drugs Market Size by Application
10.2.1 Middle East and Africa Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Pet Parasite Prevention and Control Drugs Market Size by Country
10.3.1 Middle East and Africa Pet Parasite Prevention and Control Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Overview
11.1.3 Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim Recent Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Overview
11.2.3 Bayer Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 Zoetis
11.3.1 Zoetis Corporation Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Zoetis Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
11.4 Dechra Pharmaceuticals
11.4.1 Dechra Pharmaceuticals Corporation Information
11.4.2 Dechra Pharmaceuticals Overview
11.4.3 Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dechra Pharmaceuticals Recent Developments
11.5 Chanelle Pharma
11.5.1 Chanelle Pharma Corporation Information
11.5.2 Chanelle Pharma Overview
11.5.3 Chanelle Pharma Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Chanelle Pharma Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chanelle Pharma Recent Developments
11.6 Merck Animal Health
11.6.1 Merck Animal Health Corporation Information
11.6.2 Merck Animal Health Overview
11.6.3 Merck Animal Health Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Merck Animal Health Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck Animal Health Recent Developments
11.7 Elanco
11.7.1 Elanco Corporation Information
11.7.2 Elanco Overview
11.7.3 Elanco Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Elanco Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Elanco Recent Developments
11.8 Virbac
11.8.1 Virbac Corporation Information
11.8.2 Virbac Overview
11.8.3 Virbac Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Virbac Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Virbac Recent Developments
11.9 Vetoquinol
11.9.1 Vetoquinol Corporation Information
11.9.2 Vetoquinol Overview
11.9.3 Vetoquinol Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Vetoquinol Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Vetoquinol Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pet Parasite Prevention and Control Drugs Industry Chain Analysis
12.2 Pet Parasite Prevention and Control Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pet Parasite Prevention and Control Drugs Production Mode & Process
12.4 Pet Parasite Prevention and Control Drugs Sales and Marketing
12.4.1 Pet Parasite Prevention and Control Drugs Sales Channels
12.4.2 Pet Parasite Prevention and Control Drugs Distributors
12.5 Pet Parasite Prevention and Control Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pet Parasite Prevention and Control Drugs Industry Trends
13.2 Pet Parasite Prevention and Control Drugs Market Drivers
13.3 Pet Parasite Prevention and Control Drugs Market Challenges
13.4 Pet Parasite Prevention and Control Drugs Market Restraints
14 Key Findings in The Global Pet Parasite Prevention and Control Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のペット用寄生虫予防＆制御薬市場インサイト及び予測（局所薬、注射薬、経口薬）(Global Pet Parasite Prevention and Control Drugs Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • イロプロスト薬の世界市場見通し2023年-2029年
  • 世界のオラパリブ薬市場インサイト及び予測（100mg、150mg）
  • 世界の職業病予防ソリューション市場インサイト及び予測（薬物予防、身体予防、運動予防）
  • 世界の動物用寄生虫予防・駆除薬市場インサイト及び予測（外用薬、注射薬、内服薬）
  • 世界の感染予防・制御装置市場インサイト及び予測（滅菌、洗浄・消毒製品、保護バリア、その他）